BLADDER CANCER
 
Worse perioperative outcomes seen in bladder Ca patients ≥80 years
A study investigating discharge destination and perioperative complications after radical cystectomy provides useful data for risk stratification and preoperative counseling of patients 80 years of age and older, said Hayden M. Hill, MD.
Get the data
ADVERTISEMENT
 
Pyruvate kinase appears to be bladder cancer marker
Pyruvate kinase, a primary driver of tumor glycolysis, is promising both as a biomarker of bladder cancer and as a drug target, researchers report.
Learn more
ADVERTISEMENT
 
Older women who quit smoking greatly reduce bladder cancer risk
Smoking’s strong impact on bladder cancer risk among men and women is clear, but a new study shows quitting smoking can greatly reduce risk of the cancer among menopausal women.
Dr. Hendryx discusses findings
 
ADVERTISEMENT
Start 2020 with a Cysview® Reference Center Visit
See hexaminolevulinate HCl in action in the operating room or clinic setting. Get answers and tips from an expert user. Travel and meal expenses are reimbursed. RSVP to discuss available dates and locations

 
MORE FROM UROLOGY TIMES
 
Financial toxicity prevalent with bladder Ca patients
How has FDA label change affected treatment of advanced bladder Ca?
ADVERTISEMENT
High-success approaches for bigger, more complex stones
Seth K. Bechis, MD, discusses a percutaneous approach to treating a 52-year-old patient with a large 4cm obstructed proximal ureteral stone. He highlights the steps and tools used in his technique, including effective lithotripter settings.
Watch the video now.
 
JOB OPPORTUNITIES
 
NY-WNY Urology Associates
VT-University of Vermont
VT-University of Vermont